جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

5 مُخرَج نتائج البحث عن «Immunotherapy»

مقالمفتوح (مستودع)20253استشهاد· Semantic Scholar

Deciphering immune evasion mechanisms in precision oncology: insights from single-cell multiomics approaches

International Journal of Surgery · مجلد 112 (2) · 4563-4574

BACKGROUND: Cancer poses a persistent global health challenge, and one of its most formidable characteristics is the ability to evade immune detection. Understanding these immune evasion mechanisms is essential for improving therapeutic outcomes, especially in the era of personalized medicine. Recent advances in single-cell multiomics technologies have opened new avenues for exploring tumor-immune interactions at unprecedented resolution. OBJECTIVE: This review aims to critically examine how single-cell multiomics platforms, integrating genomics, transcriptomics, epigenomics, and proteomics, have been applied to identify immune evasion mechanisms in cancer and how these findings contribute to the development of precision oncology. METHODS: A structured literature search was conducted in PubMed, Scopus, and Web of Science, focusing on studies published between 2018 and 2025. Relevant research articles employing single-cell multiomics in the context of cancer immune evasion were selected, analyzed, and thematically organized according to the type of omics technology used and clinical relevance. RESULTS: The findings highlight that single-cell multiomics enables the detection of rare immune-resistant cellular subtypes, the identification of altered immunoregulatory pathways, and the characterization of epigenetic reprogramming events involved in immune escape. This integrative approach reveals dynamic and context-dependent mechanisms by which tumors adapt and resist immunotherapy. CONCLUSIONS: Single-cell multiomics technologies provide a comprehensive and nuanced understanding of cancer immune evasion. These insights not only explain failures in current immunotherapy strategies but also inform the development of more effective and personalized treatment interventions. The integration of these platforms into clinical research represents a significant step toward overcoming immune resistance in oncology.

tumor immune evasiontumor immune microenvironmentsingle-cell multi-omicsprecision oncology
مقالمفتوح (مستودع)20218استشهاد· Semantic Scholar

Formulation and in-vitro characterization of fast-disintegrating herbal extract sublingual immunotherapy tablet for peanut-induced allergic asthma

Saudi Journal of Biological Sciences · مجلد 29 (3) · 1283-1297

Background: Allergen immunotherapy (AIT) involves the regimen of gradually incrementing doses of the allergen, thereby inducing desensitization and tolerance. Sublingual Immunotherapy tablets (SLIT-tablets) have been formulated for several allergies and had manifested efficacy for allergic rhinitis and allergic asthma. SLIT promises an alternative method to other routes of AIT enabling patients to self-administer AIT. Objective: The study aimed to formulate fast disintegrating SLIT containing crude peanut extract for peanut-induced allergic asthma. Methods: The crude peanut extract was prepared by a simple extraction method and was subjected to quantitative and qualitative analysis. The extract was also characterised for its physical properties. The preformulation study for the extract and excipients of the tablet was performed using FT-IR spectroscopy and Differential scanning calorimetry. The tablet powder blends were characterised for pre-compression properties. The SLIT tablets were developed by direct compression and the post-compression evaluation was performed. Results: The results of the quantitative and qualitative analysis of extract confirmed the presence of peanut proteins in the extract. The preformulation studies using FT-IR spectroscopy and Differential Scanning Calorimetry revealed that there is no significant interaction between the CPE and excipients. The pre-compression characterisation showed that the powder blends had good flowproperties. Three doses of SLIT tablets were formulated with each dose containing four batches and the tablet of each dose was optimized by studying the effect of varying concentrations of super disintegrants on disintegration time and dissolution rate. The post compression characterization of the tablets was performed and the optimized batch of the three doses with the concentration of 5% crospovidone and 2% croscarmellose sodium showed less wetting time and high-water absorption ratio, shorter disintegration time of 14secs and maximum drug release of >90% within 2-3 min. Conclusion: The results indicated the suitability of formulated SLIT tablets for peanut induced allergic asthma.

sublingual immunotherapypeanut allergyallergic asthmafast disintegrating tablets
مقالوصول مفتوح20215استشهاد· Semantic Scholar

Primary Vaginal Amelanotic Melanoma: A Diagnostic Conundrum

Cureus · مجلد 13 (12) · e20796-e20796

Primary vaginal amelanotic melanoma (PVAM) is an exceptionally rare aggressive malignancy having a poor prognosis. PVAM shows a high incidence of recurrence, regional spread, and early metastasis that contribute to a high mortality rate. The majority of primary vaginal malignant melanomas are pigmented, and <10% are amelanotic. Because of the absence of melanin pigment in tumor cells, PVAM may mimic other common vaginal malignancies having a more favorable prognosis and may lead to diagnostic conundrum. Knowledge regarding varied histological features and immunohistochemistry can help in establishing the correct diagnosis. Magnetic resonance imaging (MRI) provides valuable information related to the extent of vaginal malignancy and the involvement of regional lymph nodes. Conservative surgery is used for early-stage disease, whereas advanced stages are treated with radical surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapy.

vaginal melanomadiagnostic challengesimmunohistochemistrymagnetic resonance imaging
مقالوصول مفتوح20211استشهاد· Semantic Scholar

Malignant Otitis Externa in a 20-Year-Old Male Patient With Erdheim-Chester Disease: A Case Report

Cureus · مجلد 13 (12) · e20498-e20498

Malignant otitis externa (MOE) is an uncommon, potentially life-threatening, invasive infection of the external auditory canal and lateral skull base. It is mainly seen in older adults with diabetes or immunocompromised patients and rarely seen in children. Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis disorder. It is a multisystem disease with a poorly understood etiology. It commonly affects the skeletal system, central nervous system (CNS), cardiovascular system, lungs, retroperitoneum, kidneys, and skin. CNS involvement confers poor prognosis and reduced response to treatment. Cardiovascular involvement is another indicator of poor prognosis. This report describes the case of a 20-year-old male with ECD who had bilateral malignant otitis externa/skull base osteomyelitis and hearing loss. The patient was not responding well to treatment. He was on intravenous antibiotics, underwent left mastoidectomy, received targeted immunotherapy, and had four rounds of chemotherapy. The patient died after six months from the diagnosis and targeted treatment, which indicates the aggressiveness of the disease. MOE should be suspected in any patient presenting with intractable otalgia with otorrhea that is not responsive to local treatment for uncomplicated otitis externa or otalgia with temporomandibular joint (TMJ) pain aggravated by chewing. This is the first report of malignant otitis externa in a young patient with ECD to the best of the author's knowledge. This case emphasizes the importance of suspecting MOE in young patients, especially if the risk factors of the disease are present because early diagnosis can prevent or minimize life-threatening complications.

malignant otitis externaErdheim-Chester diseasenon-Langerhans cell histiocytosisskull base osteomyelitis